EUVIMEDEUVIMED entdecken
Open Access

Mifepristone decreases nicotine intake in dependent and non-dependent adult rats

Ranjithkumar Chellian iD, Azin Behnood-Rod, Adriaan W Bruijnzeel iD

Journal of Psychopharmacology · 2024

DOI: 10.1177/02698811241230255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Ranjithkumar Chellian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Tobacco Use Disorder, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Addiction to tobacco and nicotine products has adverse health effects and afflicts more than a billion people worldwide. Therefore, there is an urgent need for new treatments to reduce tobacco and nicotine use. Glucocorticoid receptor blockade shows promise as a novel treatment for drug abuse and stress-related disorders.

Aim

These studies aim to investigate whether glucocorticoid receptor blockade with mifepristone diminishes the reinforcing properties of nicotine in rats with intermittent or daily long access to nicotine.

Methods

The rats self-administered 0.06 mg/kg/inf of nicotine for 6 h per day, with either intermittent or daily access for 4 weeks before treatment with mifepristone. Daily nicotine self-administration models regular smoking, while intermittent nicotine self-administration models occasional smoking. To determine whether the rats were dependent, they were treated with the nicotinic acetylcholine receptor antagonist mecamylamine, and somatic signs were recorded.

Results

The rats with intermittent access to nicotine had a higher level of nicotine intake per session than those with daily access but only the rats with daily access to nicotine showed signs of physical dependence. Furthermore, mecamylamine increased nicotine intake during the first hour of access in rats with daily access but not in those with intermittent access. Mifepristone decreased total nicotine intake in rats with intermittent and daily access to nicotine. Moreover, mifepristone decreased the distance traveled and rearing in the open field test and operant responding for food pellets.

Conclusion

These findings indicate that mifepristone decreases nicotine intake but this effect may be partially attributed to the sedative effects of mifepristone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco Use DisorderSubstance Withdrawal SyndromeHumansRatsAnimalsNicotineMecamylamineMifepristoneSmokingReceptors, GlucocorticoidRats, WistarSelf AdministrationDose-Response Relationship, Drug

Stichwörter der Autor:innen

Smokingglucocorticoid receptorsmecamylaminemifepristonenicotinerats

Substanzen

NicotineMecamylamineMifepristoneReceptors, Glucocorticoid

Autor:innen und Institutionen

  • Department of Psychiatry, University of Florida, Gainesville, FL, USA.

ORCID-Profile: Ranjithkumar Chellian, Adriaan W Bruijnzeel

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Chellian, R., Behnood-Rod, A., & Bruijnzeel, A. W. (2024). Mifepristone decreases nicotine intake in dependent and non-dependent adult rats. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241230255

Vancouver

Chellian R, Behnood-Rod A, Bruijnzeel AW. Mifepristone decreases nicotine intake in dependent and non-dependent adult rats. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241230255

BibTeX
@article{Chellian2024,
  author = {Chellian, Ranjithkumar and Behnood-Rod, Azin and Bruijnzeel, Adriaan W},
  title = {Mifepristone decreases nicotine intake in dependent and non-dependent adult rats},
  journal = {Journal of Psychopharmacology},
  year = {2024},
  doi = {10.1177/02698811241230255}
}
Kostenlos starten →